Skip to content
What We Offer

From Scientific Questions
to Functional Evidence

Every research program is different. That's why every 3DxCell project is designed around your biological question, study objectives and translational goals, not around a fixed service catalogue.

Jump to Services ↓Request a Quote →(Receive a customized proposal)
Our Approach

We Don't Sell Packages. We Design Research.

Every project begins with a scientific discussion. We define the study around your research objectives, biological question, and development strategy, then design a tailored organoid-based workflow to generate the functional evidence you need.

Rather than offering fixed service packages, we build flexible research programs that align with your scientific goals, project scope, and timeline.

Science-First Design

Your scientific question drives the study design, not a rigid menu.

Tailored Study Proposal

You receive a customized study design outlining objectives, methodology, deliverables, timelines, and pricing before any work begins.

Confidential by Design

All projects are handled under strict confidentiality, with NDAs available before scientific discussions or data sharing.

Our Services

Research Services Tailored to Your Scientific Objectives

Every service is designed around your biological question, study objectives, and translational goals using standardized organoid-based tumor models and quantitative functional assays.

Your compounds are evaluated using standardized organoid-based tumor models to generate reproducible functional response data. Study design is tailored to your research objectives, tumor indication, and experimental endpoints.

DeliverableDetail
Drug Response AnalysisDose-response curves, IC50 values, viability results, and comparative response analysis, where applicable
Morphology AssessmentRepresentative bright-field images and assessment of treatment-associated morphological changes
Comprehensive Final Study ReportStudy design, assay conditions, controls, analysis methodology, statistical evaluation, and integrated interpretation of study results. Raw and processed data are provided as accompanying files.
Histopathology & Marker ProfilingH&E-based histomorphological assessment and marker-specific characterization by immunofluorescence (IF) and/or immunohistochemistry (IHC), according to study requirements
Genomic ProfilingGenomic characterization, including next-generation sequencing (NGS), according to study requirements

Typical scope: 1–5 organoid models, 1–50+ compounds. Typical duration: 4–6 weeks.

Start a Screening Project →

Evaluate combination strategies using standardized functional assays designed to assess interaction patterns across multiple therapeutic candidates and experimental conditions.

DeliverableDetail
Drug Response AnalysisDose-response curves, IC50 values, viability results, and comparative response analysis, where applicable
Combination Response AnalysisCombination response matrices, graphical summaries, and comparative assessment of combination effects. Synergy scoring using established models (e.g., Loewe, Bliss, HSA) where appropriate to the study design.
Morphology AssessmentRepresentative bright-field images and assessment of treatment-associated morphological changes
Comprehensive Final Study ReportStudy design, assay conditions, controls, analysis methodology, statistical evaluation, and integrated interpretation of study results. Raw and processed data are provided as accompanying files.
Histopathology & Marker ProfilingH&E-based histomorphological assessment and marker-specific characterization by immunofluorescence (IF) and/or immunohistochemistry (IHC), according to study requirements
Genomic ProfilingGenomic characterization, including next-generation sequencing (NGS), according to study requirements

Typical scope: 2–6 compounds in a combination matrix, 2–5 organoid models. Typical duration: 7–10 weeks.

Design a Combination Study →

Cohort-level analysis enables characterization of response heterogeneity, exploration of response-associated subgroups, and investigation of relationships between functional response and molecular features.

DeliverableDetail
Organoid EstablishmentEstablishment of organoid models from eligible study samples, with cohort-level model tracking
Histopathology & Marker ProfilingH&E-based histomorphological assessment and histological and marker-specific characterization by immunohistochemistry (IHC) and/or immunofluorescence (IF)
Genomic ProfilingGenomic characterization, including next-generation sequencing (NGS), to support molecular characterization and exploratory response associations
Morphology AssessmentRepresentative bright-field images and assessment of treatment-associated morphological changes
Drug Response AnalysisDose-response curves, IC50 values, viability results, and comparative treatment-response analysis across the PDO cohort
Cohort Response & Stratification AnalysisResponse distribution across the cohort, identification of differential response patterns and candidate responder subgroups, with comparative cohort-level analysis
Comprehensive Final Study ReportStudy design, cohort characteristics, assay conditions, controls, statistical evaluation, integrated response and stratification analysis, and interpretation of study results. Raw and processed data are provided as accompanying files.

Designed for translational research and clinical development programs.

Explore Trial Support Options →

Patient-derived tumor models are established and evaluated using a standardized research workflow to generate individualized functional drug response data.

DeliverableDetail
Organoid EstablishmentEstablishment of organoid models from eligible tumor samples
Histopathology & Marker ProfilingH&E-based histomorphological assessment and marker-specific characterization by immunofluorescence (IF) and/or immunohistochemistry (IHC)
Genomic ProfilingGenomic characterization, including next-generation sequencing (NGS), according to project requirements
Drug Response AnalysisDose-response curves, IC50 values, viability results, and comparative response analysis, where applicable
Morphology AssessmentRepresentative bright-field images and assessment of treatment-associated morphological changes
Comprehensive Final Study ReportStudy design, assay conditions, controls, analysis methodology, statistical evaluation, and integrated interpretation of study results. Raw and processed data are provided as accompanying files.

For Research Use Only. Results are intended to support research and are not intended for clinical diagnosis or to independently determine, recommend, or guide treatment for an individual patient.

Typical scope: 1–50 patient-derived models. Typical duration: 7–10 weeks.

Discuss a Precision Medicine Project →

Not every research question fits a predefined service. We collaborate with our partners to design customized organoid-based studies that align with specific experimental objectives, tumor models, endpoints, and project requirements.

Typical applications

  • Novel therapeutic evaluation
  • Mechanistic studies
  • Biomarker research
  • Resistance modeling
  • Longitudinal studies
  • Custom assay development
  • Translational research projects
Describe Your Project →
Capabilities

Scientific Capabilities of the 3DxCell Platform

Standardized laboratory workflows, functional assays, and analytical tools supporting high-quality translational oncology research.

Organoid Platform

  • Human-derived organoid model establishment
  • Three-dimensional tumor model culture
  • Tumor-type optimized culture workflows
  • Model expansion and biobanking
  • Standardized recovery and quality assessment

Model Characterization

  • Histopathological assessment
  • Immunophenotypic characterization
  • Molecular profiling (optional)
  • Identity and quality verification
  • Quality-controlled model selection

Functional Assays

  • Quantitative drug response profiling
  • Dose–response studies
  • Combination therapy evaluation
  • Imaging-based functional analysis
  • Multiparametric endpoint assessment

Data Science & Reporting

  • Functional response analysis
  • Comparative model evaluation
  • Biomarker association analysis
  • Scientific data visualization
  • Structured research reporting
Getting Started

From First Discussion to Actionable Data in Four Steps

A structured, transparent path from intake call to delivered report.

  1. ~30–60 min

    Scientific Consultation

    Tell us about your compound, indication, and research objectives. We assess feasibility and ask the right scientific questions. This call is free, informal, and confidential.

  2. 3–5 days

    Project Proposal

    We deliver a comprehensive written proposal: study design, 3D model selection, assay formats, deliverables, timelines, and transparent pricing, typically within 5 business days.

  3. 1–2 weeks

    Kickoff & Sample Logistics

    Agreement finalized and dedicated project lead assigned. We coordinate sample acquisition protocols, shipping conditions, and project timelines.

  4. ~6–8 weeks total

    Report & Debrief

    Final scientific report delivered. We walk through findings, address technical questions, and discuss implications for your therapeutic pipeline. Data delivered in export-ready formats.

Ready?

Let's Design Your Experiment.

Tell us about your compound and we'll come back with a tailored proposal.

Book a Meeting →(Discuss your study design)Request a Quote →(Receive a customized proposal)